clascoteronecb-03-01androgenetic alopecia
CB-03-01 (Clascoterone): What Real-World Results Show for Hair Loss
Clinical trials of CB-03-01 (clascoterone) show +14.3 terminal hairs per cm² with zero systemic hormonal suppression. Here is how this topical androgen receptor blocker works, how it compares to finasteride, and what the human data actually proves.
Nov 6, 2026·10 days ago